Klaus H.W. Böker

Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study

Hans J. Schlitt, Annette Barkmann, Klaus H.W. Böker et al. · The Lancet · 2001 · 254 citations

Urology, Mycophenolate Mofetil, Kidney Transplant +10

Hypermetabolism in clinically stable patients with liver cirrhosis

Manfred J. Müller, Joachim Böttcher, O. Selberg et al. · American Journal of Clinical Nutrition · 1999 · 243 citations

Stable Patients, Hepatology, Liver Physiology +7

Long–Term Outcome of Hepatitis C Virus Infection After Liver Transplantation

Klaus H.W. Böker, G. Dalley, Mathias Bähr et al. · Hepatology · 1997 · 218 citations · Full text

Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation – possible role of mutations in the YMDD motif prior totransplantation as a risk factor for reinfection

Jens Rosenau, Mathias Bähr, Hans L. Tillmann et al. · Journal of Hepatology · 2001 · 197 citations

Transplantation, Hepatology, Viral Hepatitis +11

Association between fulminant hepatic failure and a strain of GBV virus C

Stefan Heringlake, Sabine Osterkamp, Christian Trautwein et al. · The Lancet · 1996 · 195 citations

Hepatic Disorders, Hepatology, Hepatitis C +13